Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

A Three-dimensional Ex Vivo Viability Assay Reveals a Strong Correlation Between Response to Targeted Inhibitors and Mutation Status in Melanoma Lymph Node Metastases.

Flørenes VA, Flem-Karlsen K, McFadden E, Bergheim IR, Nygaard V, Nygård V, Farstad IN, Øy GF, Emilsen E, Giller-Fleten K, Ree AH, Flatmark K, Gullestad HP, Hermann R, Ryder T, Wernhoff P, Mælandsmo GM.

Transl Oncol. 2019 Jul;12(7):951-958. doi: 10.1016/j.tranon.2019.04.001. Epub 2019 May 13.

2.

Responsiveness to PD-1 Blockade in End-Stage Colon Cancer with Gene Locus 9p24.1 Copy-Number Gain.

Ree AH, Nygaard V, Russnes HG, Heinrich D, Nygaard V, Johansen C, Bergheim IR, Hovig E, Beiske K, Negård A, Børresen-Dale AL, Flatmark K, Mælandsmo GM.

Cancer Immunol Res. 2019 May;7(5):701-706. doi: 10.1158/2326-6066.CIR-18-0777. Epub 2019 Feb 25.

PMID:
30804006
3.

Molecular signatures reflecting microenvironmental metabolism and chemotherapy-induced immunogenic cell death in colorectal liver metastases.

Østrup O, Dagenborg VJ, Rødland EA, Skarpeteig V, Silwal-Pandit L, Grzyb K, Berstad AE, Fretland ÅA, Mælandsmo GM, Børresen-Dale AL, Ree AH, Edwin B, Nygaard V, Flatmark K.

Oncotarget. 2017 Jul 18;8(44):76290-76304. doi: 10.18632/oncotarget.19350. eCollection 2017 Sep 29.

4.

Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimate.

Ree AH, Russnes HG, Heinrich D, Dueland S, Boye K, Nygaard V, Silwal-Pandit L, Østrup O, Hovig E, Nygaard V, Rødland EA, Nakken S, Øien JT, Johansen C, Bergheim IR, Skarpeteig V, Sathermugathevan M, Sauer T, Lund-Iversen M, Beiske K, Nasser S, Julsrud L, Reisse CH, Ruud EA, Flørenes VA, Hagene KT, Aas E, Lurås H, Johnsen-Soriano S, Geitvik GA, Lingjærde OC, Børresen-Dale AL, Mælandsmo GM, Flatmark K.

ESMO Open. 2017 May 2;2(2):e000158. doi: 10.1136/esmoopen-2017-000158. eCollection 2017.

5.

Th17 Polarization under Hypoxia Results in Increased IL-10 Production in a Pathogen-Independent Manner.

Volchenkov R, Nygaard V, Sener Z, Skålhegg BS.

Front Immunol. 2017 Jun 19;8:698. doi: 10.3389/fimmu.2017.00698. eCollection 2017.

6.

Reply to Towfic and others' letter to the editor.

Nygaard V, Rødland EA, Hovig E.

Biostatistics. 2017 Jul 1;18(3):586-587. doi: 10.1093/biostatistics/kxx001. No abstract available.

PMID:
28334081
7.

Subtype-specific micro-RNA expression signatures in breast cancer progression.

Haakensen VD, Nygaard V, Greger L, Aure MR, Fromm B, Bukholm IR, Lüders T, Chin SF, Git A, Caldas C, Kristensen VN, Brazma A, Børresen-Dale AL, Hovig E, Helland Å.

Int J Cancer. 2016 Sep 1;139(5):1117-28. doi: 10.1002/ijc.30142. Epub 2016 May 9.

8.

Fibroblast-induced switching to the mesenchymal-like phenotype and PI3K/mTOR signaling protects melanoma cells from BRAF inhibitors.

Seip K, Fleten KG, Barkovskaya A, Nygaard V, Haugen MH, Engesæter BØ, Mælandsmo GM, Prasmickaite L.

Oncotarget. 2016 Apr 12;7(15):19997-20015. doi: 10.18632/oncotarget.7671.

9.

Methods that remove batch effects while retaining group differences may lead to exaggerated confidence in downstream analyses.

Nygaard V, Rødland EA, Hovig E.

Biostatistics. 2016 Jan;17(1):29-39. doi: 10.1093/biostatistics/kxv027. Epub 2015 Aug 13.

10.

Metabolic reprogramming supports the invasive phenotype in malignant melanoma.

Bettum IJ, Gorad SS, Barkovskaya A, Pettersen S, Moestue SA, Vasiliauskaite K, Tenstad E, Øyjord T, Risa Ø, Nygaard V, Mælandsmo GM, Prasmickaite L.

Cancer Lett. 2015 Sep 28;366(1):71-83. doi: 10.1016/j.canlet.2015.06.006. Epub 2015 Jun 18.

PMID:
26095603
11.

Melanoma brain colonization involves the emergence of a brain-adaptive phenotype.

Nygaard V, Prasmickaite L, Vasiliauskaite K, Clancy T, Hovig E.

Oncoscience. 2014 Jan 10;1(1):82-94. eCollection 2014.

12.

Identifying pathogenic processes by integrating microarray data with prior knowledge.

Nygård S, Reitan T, Clancy T, Nygaard V, Bjørnstad J, Skrbic B, Tønnessen T, Christensen G, Hovig E.

BMC Bioinformatics. 2014 Apr 24;15:115. doi: 10.1186/1471-2105-15-115.

13.

Metastasis-associated protein S100A4 induces a network of inflammatory cytokines that activate stromal cells to acquire pro-tumorigenic properties.

Bettum IJ, Vasiliauskaite K, Nygaard V, Clancy T, Pettersen SJ, Tenstad E, Mælandsmo GM, Prasmickaite L.

Cancer Lett. 2014 Mar 1;344(1):28-39. doi: 10.1016/j.canlet.2013.10.036. Epub 2013 Nov 8.

PMID:
24215866
14.

The Genomic HyperBrowser: an analysis web server for genome-scale data.

Sandve GK, Gundersen S, Johansen M, Glad IK, Gunathasan K, Holden L, Holden M, Liestøl K, Nygård S, Nygaard V, Paulsen J, Rydbeck H, Trengereid K, Clancy T, Drabløs F, Ferkingstad E, Kalas M, Lien T, Rye MB, Frigessi A, Hovig E.

Nucleic Acids Res. 2013 Jul;41(Web Server issue):W133-41. doi: 10.1093/nar/gkt342. Epub 2013 Apr 30.

15.

The differential disease regulome.

Sandve GK, Gundersen S, Rydbeck H, Glad IK, Holden L, Holden M, Liestøl K, Clancy T, Drabløs F, Ferkingstad E, Johansen M, Nygaard V, Tøstesen E, Frigessi A, Hovig E.

BMC Genomics. 2011 Jul 7;12:353. doi: 10.1186/1471-2164-12-353.

16.

Immunological network signatures of cancer progression and survival.

Clancy T, Pedicini M, Castiglione F, Santoni D, Nygaard V, Lavelle TJ, Benson M, Hovig E.

BMC Med Genomics. 2011 Mar 31;4:28. doi: 10.1186/1755-8794-4-28.

17.

The Genomic HyperBrowser: inferential genomics at the sequence level.

Sandve GK, Gundersen S, Rydbeck H, Glad IK, Holden L, Holden M, Liestøl K, Clancy T, Ferkingstad E, Johansen M, Nygaard V, Tøstesen E, Frigessi A, Hovig E.

Genome Biol. 2010;11(12):R121. doi: 10.1186/gb-2010-11-12-r121. Epub 2010 Dec 23.

18.

Methods for quantitation of gene expression.

Nygaard V, Hovig E.

Front Biosci (Landmark Ed). 2009 Jan 1;14:552-69. Review.

PMID:
19273085
19.

Cell sampling and global nucleic acid amplification.

Nygaard V, Hovig E.

SEB Exp Biol Ser. 2008;61:17-36. Review. No abstract available.

PMID:
18709735
20.

Validation of oligoarrays for quantitative exploration of the transcriptome.

Nygaard V, Liu F, Holden M, Kuo WP, Trimarchi J, Ohno-Machado L, Cepko CL, Frigessi A, Glad IK, Wiel MA, Hovig E, Lyng H.

BMC Genomics. 2008 May 30;9:258. doi: 10.1186/1471-2164-9-258.

21.
22.

Limitations of mRNA amplification from small-size cell samples.

Nygaard V, Holden M, Løland A, Langaas M, Myklebost O, Hovig E.

BMC Genomics. 2005 Oct 27;6:147.

23.

Constitutive expression of the AP-1 transcription factors c-jun, junD, junB, and c-fos and the marginal zone B-cell transcription factor Notch2 in splenic marginal zone lymphoma.

Trøen G, Nygaard V, Jenssen TK, Ikonomou IM, Tierens A, Matutes E, Gruszka-Westwood A, Catovsky D, Myklebost O, Lauritzsen G, Hovig E, Delabie J.

J Mol Diagn. 2004 Nov;6(4):297-307.

24.

FigSearch: a figure legend indexing and classification system.

Liu F, Jenssen TK, Nygaard V, Sack J, Hovig E.

Bioinformatics. 2004 Nov 1;20(16):2880-2. Epub 2004 May 14.

PMID:
15145804
25.

ABI3 mediates expression of the peroxiredoxin antioxidant AtPER1 gene and induction by oxidative stress.

Haslekås C, Grini PE, Nordgard SH, Thorstensen T, Viken MK, Nygaard V, Aalen RB.

Plant Mol Biol. 2003 Oct;53(3):313-26.

PMID:
14750521
26.

Seed 1-cysteine peroxiredoxin antioxidants are not involved in dormancy, but contribute to inhibition of germination during stress.

Haslekås C, Viken MK, Grini PE, Nygaard V, Nordgard SH, Meza TJ, Aalen RB.

Plant Physiol. 2003 Nov;133(3):1148-57. Epub 2003 Oct 2.

27.

Effects of mRNA amplification on gene expression ratios in cDNA experiments estimated by analysis of variance.

Nygaard V, Løland A, Holden M, Langaas M, Rue H, Liu F, Myklebost O, Fodstad Ø, Hovig E, Smith-Sørensen B.

BMC Genomics. 2003 Mar 23;4(1):11. Epub 2003 Mar 23.

28.

MArray: analysing single, replicated or reversed microarray experiments.

Wang J, Nygaard V, Smith-Sørensen B, Hovig E, Myklebost O.

Bioinformatics. 2002 Aug;18(8):1139-40.

PMID:
12176840
29.

The expression of a peroxiredoxin antioxidant gene, AtPer1, in Arabidopsis thaliana is seed-specific and related to dormancy.

Haslekås C, Stacy RA, Nygaard V, Culiáñez-Macià FA, Aalen RB.

Plant Mol Biol. 1998 Apr;36(6):833-45.

PMID:
9580097
30.

Ultrastructure of striations in carious human enamel.

Simmelink JW, Nygaard VK.

Caries Res. 1982;16(2):179-88. No abstract available.

PMID:
6951641
31.

Vitamin D resistant rickets. A review and case report of an adolescent boy with a history of dental problems.

Vasilakis GJ, Nygaard VK, DiPalma DM.

J Oral Med. 1980 Jan-Mar;35(1):19-26. No abstract available.

PMID:
6246228
32.

Disturbances and defects in enamel development.

Simmelink JW, Nygaard VK.

J Dent Res. 1979 Mar;58(Spec Issue B):717-24.

PMID:
283114
33.

Ultrastructural study of the resin infiltration zone in acid-treated human enamel.

Nygaard VK, Simmelink JW.

Arch Oral Biol. 1978;23(12):1151-6. No abstract available.

PMID:
378201
34.

Structural aspects of dental caries.

Scott DB, Simmelink JW, Nygaard V.

J Dent Res. 1974 Mar-Apr;53(2):165-78. Review. No abstract available.

PMID:
4591965
35.

Theory for the sequence of human and rat enamel dissolution by acid and by EDTA: a correlated scanning and transmission electron microscope study.

Simmelink JW, Nygaard VK, Scott DB.

Arch Oral Biol. 1974 Feb;19(2):183-97. No abstract available.

PMID:
4212466

Supplemental Content

Loading ...
Support Center